Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
Healthcare
$13.31 +5.43%
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
52W Low $13.50High $25.93
Volume 0.21M
Average 0.38M
LTGO Common Stock Issued
Cash raised by issuing new shares.
No reported Common Stock Issued figures are available to summarize.
Common Stock Issued history
Currency unavailable · from the cash flow
No Common Stock Issued data reported for this period type.
Common Stock Issued vs competitors
How LTGO compares with its peers on the latest reported figures
LTGO Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $15.91M USD | -55.1% | +562.2% | 47.0% | |
| LTM Mar 2026 | $4.93M USD | -41.3% | — | 0.6% | |
| LTM Mar 2026 | $3.29M USD | +141.4% | -50.6% | 0.4% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -41.3% | +255.8% | 0.6% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.